Purchase Order 75F40120P00366
- Not listed
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order valued at $750,244.75 to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a Multiparameter Flow Cytometric Cell Sorter with Spectral Analysis and Cell Imaging (Imaging Cell Sorter). The equipment will be delivered to and utilized by the FDA's Center for Biologics Evaluation and Research facility in San Jose, California, under the terms of the order...
- The Department of Health and Human Services Food and Drug Administration awarded a fixed-price purchase order to Becton, Dickinson and Company (BD) to provide maintenance and support services for a BD FACSAria II cell sorter at the FDA's Center for Biologics Evaluation and Research (CBER) in Silver Spring, Maryland. The $107,568.00 contract has a completion date of December 14, 2022 and does not utilize a small business set-aside. BD, a leading medical technology manufacturer, will provide...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a delivery order valued at $61,260.74 for a flow cytometer system and associated service agreement by the Food and Drug Administration. The contract, awarded July 18, 2014, with an ultimate completion date of August 31, 2019, represents a firm fixed-price delivery order with no small business set-aside. The place of performance is San Jose, California. This award provides the FDA with advanced...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a delivery order for a FACSARIA Illumina 4-Laser System Service Agreement by the Food and Drug Administration on September 9, 2020. This firm fixed-price contract, valued at $76.8K with an ultimate completion date of September 22, 2025, represents a child contract under BD's parent company framework. The contract involves the supply and servicing of specialized flow cytometry equipment at the...
- The U.S. Food and Drug Administration awarded a $62,449.13 delivery order contract to Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, for preventative and corrective/remedial maintenance repair services for a FACSCanto II Flow Cytometer and high-throughput sampler. This firm fixed-price delivery order was awarded on August 23, 2018, with an ultimate completion date of September 13, 2023, with performance to occur in Jefferson, Arkansas. The contract...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $521,896 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems And Reagents Division for an integrated BD FACSAria Fusion cell sorter and biosafety cabinet solution. The solicitation sought a cell sorter capable of 4-way tube sorting and automatic cell deposition into 96-well plates at rates over 50,000 events per second...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a delivery order contract valued at $9,312.48 for a FACSAria 2 Laser System on April 1, 2007, with completion targeted for September 30, 2007. The work was performed in San Jose, California. This contract was awarded on a full and open competitive basis without small business set-aside designation. BD Biosciences specializes in providing sophisticated flow cytometry instruments, reagents, and...
- This delivery order, issued by the Food and Drug Administration on February 17, 2021, awards Becton, Dickinson and Company (BD Biosciences division) $33,516.73 for corrective/remedial repair and preventive maintenance services on an LSRII flow cytometer, high-throughput sampler, and FACS flow supply system located in San Jose, California. The contract was executed under the Multiple Award Schedule vehicle and utilized firm fixed price terms without a small business set-aside. This...
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a delivery order valued at $247,609 on February 13, 2006, for the procurement of a FACSARIA Workstation Bundle. The contract was executed without a small business set-aside designation on a full and open competition basis, with performance completed by the ultimate completion date of June 13, 2006, and work performed in San Jose, California. BD Biosciences specializes in providing sophisticated flow cytometry and...
- The U.S. Food and Drug Administration (FDA) awarded a $431,505.49 firm-fixed-price delivery order contract to Becton, Dickinson and Company (BD) for a flow cytometry system with 5 one-year post-warranty maintenance options. The contract is not set aside. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications. The delivery order likely supports the FDA's work in evaluating and approving medical...
The Food and Drug Administration awarded a $206,010 firm fixed-price purchase order to Becton, Dickinson and Company (BD Biosciences division) on July 14, 2020, for a BD FACSAria II SORP Cell Sorter (Serial Number P69500102) to be delivered to San Jose, California. This award was made without a small business set-aside and represents a single equipment acquisition under a standard purchase order vehicle with an ultimate completion date of September 3, 2025. The FACSAria II is a sophisticated flow cytometry instrument used for cell sorting and analysis, enabling the FDA to conduct advanced biomedical research and diagnostic testing capabilities essential to the agency's mission of protecting public health through scientific investigation and regulatory decision-making. BD Biosciences, the awardee operating division of parent company Becton, Dickinson and Company, is an established supplier of flow cytometry systems and laboratory instrumentation to federal agencies. The company maintains significant existing relationships with the National Institutes of Health, Department of Veterans Affairs, Defense Health Agency, and other government entities through multiple indefinite delivery vehicles and blanket purchase agreements valued in aggregate at millions of dollars. This procurement reflects FDA's reliance on BD's specialized capabilities in providing advanced cell analysis platforms and associated technical support to support the agency's regulatory science and research objectives.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
BD FACSAria II Cell Sorter Maintenance & Support Services | FDA-SOL-1225491 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 6/19/20, 9:55 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $41.2k | 5/31/23 | |
| P00003 | Exercise an Option | $41.2k | 9/1/22 | |
| P00002 | Other Administrative Action | $0 | 4/1/22 | |
| P00001 | Exercise an Option | $41.2k | 4/29/21 | |
| Not listed | Not listed | $41.2k | 7/14/20 |